Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer

Tina Idris; Peter Krippl; Uwe Lang; Edgar Petru

首页> 外文期刊>Breast care >Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer

【24h】

Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer

机译：拉帕替尼和卡培他滨在长期大量治疗的ErbB2阳性转移性乳腺癌患者中的长期疾病控制

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

The optimal sequence of systemic palliative chemotherapy in metastatic breast cancer is unknown.

机译：转移性乳腺癌中全身姑息化疗的最佳顺序尚不清楚。

著录项

来源
《Breast care》 |2010年第5期|共页
作者
Tina Idris; Peter Krippl; Uwe Lang; Edgar Petru;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类泌尿生殖器肿瘤;
关键词

相似文献

外文文献
中文文献
专利

1. Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer [J] . Tina Idris, Peter Krippl, Uwe Lang, Breast care . 2010,第5期

机译：拉帕替尼和卡培他滨在长期大量治疗的ErbB2阳性转移性乳腺癌患者中的长期疾病控制
2. Lapatinib plus capecitabine versus capecitabine alone for ErbB2-positive metastatic breast cancer (MBC) – Quality of Life (QOL) assessment [J] . X.Zhou, A.Segreti, D.Cella, European Journal of Cancer Supplements . 2008,第7期

机译：拉帕替尼加卡培他滨与单用卡培他滨治疗ErbB2阳性转移性乳腺癌（MBC）–生活质量（QOL）评估
3. Lapatinib plus capecitabine versus capecitabine alone for ErbB2-positive metastatic breast cancer (MBC) – Quality of Life (QOL) assessment [J] . X.Zhou, A.Segreti, D.Cella, European Journal of Cancer Supplements . 2008,第7期

机译：拉帕替尼加卡培他滨与单用卡培他滨治疗ErbB2阳性转移性乳腺癌（MBC）–生活质量（QOL）评估
4. Minimal Residual Disease in Bone Marrow and Peripheral Blood of Patients with Metastatic Breast Cancer [C] . Joachim Bischoff, Wolfgang Janni, Michael Dahm, International Meeting on Molecular Staging on Cancer . 2003

机译：转移性乳腺癌患者骨髓和外周血中的最小残留疾病
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer [O] . Tina Idris, Peter Krippl, Uwe Lang, 2010

机译：拉帕替尼和卡培他滨在长期大量治疗的ErbB2阳性转移性乳腺癌患者中的长期疾病控制
7. Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer [O] . Idris, Tina, Krippl, Peter, Lang, Uwe, 2010

机译：拉帕替尼和卡培他滨在长期大量治疗的ErbB2阳性转移性乳腺癌患者中的长期疾病控制

Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅